| David C Liu, MD | |
|
9961 Sierra Ave, Fontana, CA 92335-6720 | |
| (909) 427-3910 | |
| Not Available |
| Full Name | David C Liu |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 28 Years |
| Location | 9961 Sierra Ave, Fontana, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073661856 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | A63050 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kaiser Foundation Hospital Fontana/ontario | Fontana, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southern California Permanente Medical Group | 6002729175 | 7951 |
News Archive
CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced the initiation of enrollment in an open-label Phase 1b clinical trial designed to investigate the preliminary safety and activity of aldoxorubicin plus gemcitabine in subjects with metastatic solid tumors.
The study showed, 30 days after receiving the stem cells by injection into their hearts, patients improved an average of 41 percent in their hearts' pumping efficiency and the distance they could walk nonstop increased by 72 percent in a standard test widely used to assess heart patients.
Magnetic resonance imaging (MRI) isn't just for capturing detailed images of the body's anatomy. Thanks to novel imaging reagents and technology developed by Carnegie Mellon University scientist Eric Ahrens, MRI can be used to visualize - with "exquisite" specificity - cell populations of interest in the living body. The ability to non-invasively locate and track cells, such as immune cells, will greatly aid the study and treatment of cancer, inflammation, and autoimmune diseases, as well as provide a tool for advancing clinical translation of the emerging field of cellular regenerative medicine, by tracking stem cells for example.
UT Southwestern researchers have found that an enzyme on the surface of some lung cancer cells helps feed the cancer, making it a tempting treatment target.
Taking aspirin on a daily basis may lower women's risk of a particular type of breast cancer, according to results published in BioMed Central's open access journal Breast Cancer Research.
› Verified 1 days ago
| Entity Name | Southern California Permanente Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316979834 PECOS PAC ID: 6002729175 Enrollment ID: O20040126000823 |
News Archive
CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced the initiation of enrollment in an open-label Phase 1b clinical trial designed to investigate the preliminary safety and activity of aldoxorubicin plus gemcitabine in subjects with metastatic solid tumors.
The study showed, 30 days after receiving the stem cells by injection into their hearts, patients improved an average of 41 percent in their hearts' pumping efficiency and the distance they could walk nonstop increased by 72 percent in a standard test widely used to assess heart patients.
Magnetic resonance imaging (MRI) isn't just for capturing detailed images of the body's anatomy. Thanks to novel imaging reagents and technology developed by Carnegie Mellon University scientist Eric Ahrens, MRI can be used to visualize - with "exquisite" specificity - cell populations of interest in the living body. The ability to non-invasively locate and track cells, such as immune cells, will greatly aid the study and treatment of cancer, inflammation, and autoimmune diseases, as well as provide a tool for advancing clinical translation of the emerging field of cellular regenerative medicine, by tracking stem cells for example.
UT Southwestern researchers have found that an enzyme on the surface of some lung cancer cells helps feed the cancer, making it a tempting treatment target.
Taking aspirin on a daily basis may lower women's risk of a particular type of breast cancer, according to results published in BioMed Central's open access journal Breast Cancer Research.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David C Liu, MD 9961 Sierra Ave, Fontana, CA 92335-6720 Ph: (909) 427-3910 | David C Liu, MD 9961 Sierra Ave, Fontana, CA 92335-6720 Ph: (909) 427-3910 |
News Archive
CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced the initiation of enrollment in an open-label Phase 1b clinical trial designed to investigate the preliminary safety and activity of aldoxorubicin plus gemcitabine in subjects with metastatic solid tumors.
The study showed, 30 days after receiving the stem cells by injection into their hearts, patients improved an average of 41 percent in their hearts' pumping efficiency and the distance they could walk nonstop increased by 72 percent in a standard test widely used to assess heart patients.
Magnetic resonance imaging (MRI) isn't just for capturing detailed images of the body's anatomy. Thanks to novel imaging reagents and technology developed by Carnegie Mellon University scientist Eric Ahrens, MRI can be used to visualize - with "exquisite" specificity - cell populations of interest in the living body. The ability to non-invasively locate and track cells, such as immune cells, will greatly aid the study and treatment of cancer, inflammation, and autoimmune diseases, as well as provide a tool for advancing clinical translation of the emerging field of cellular regenerative medicine, by tracking stem cells for example.
UT Southwestern researchers have found that an enzyme on the surface of some lung cancer cells helps feed the cancer, making it a tempting treatment target.
Taking aspirin on a daily basis may lower women's risk of a particular type of breast cancer, according to results published in BioMed Central's open access journal Breast Cancer Research.
› Verified 1 days ago
Nainesh K. Gandhi, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 9985 Sierra Ave, Fontana, CA 92335 Phone: 866-454-3485 | |
Blanca E. Viramontes, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 9961 Sierra Ave, Fontana, CA 92335 Phone: 909-427-3910 | |
Dr. Paymon Mesgarzadeh, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 9985 Sierra Ave, Fontana, CA 92335 Phone: 909-427-5000 | |
Kathryn Chang Lin, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 16465 Sierra Lakes Pkwy, Ste 245, Fontana, CA 92336 Phone: 909-829-7337 Fax: 909-829-1218 | |
Lih-jiau Chen, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 9961 Sierra Ave, Fontana, CA 92335 Phone: 909-427-3910 | |
Tommy Tiong Hien Oei, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 9961 Sierra Ave, Fontana, CA 92335 Phone: 909-427-3910 | |
Edmond C. Hui, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 9961 Sierra Ave, Fontana, CA 92335 Phone: 909-427-3910 |